a TechBio company focused on transforming clinical trials through artificial intelligence
Biorce has raised €52M across 3 funding rounds from 12 investors, most recently a Series A round in Feb 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-02-02 | Series A | €44M | Albert Nieto,Angel Investors,Arthur Mensch,DST Global Partners,Mustard Seed Maze,Nik Storonsky+3 more | View deal → |
| 2025-07-08 | Other | €5.0M | Norrsken VC | View deal → |
| 2024-11-15 | Other | €3.5M | Mustard Seed Maze,Outsized Ventures,Pathena Family Office,Plug and Play Tech Center,YZR Capital | View deal → |
